Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC EPI-7170 | 2139288-26-7 | 99.9% | 540.88 | 5 MG
Supplier: Medchemexpress LLC HY1501025MG
EPI-7170 is a ralaniten analogue and a potent antagonist of the androgen receptor (AR) N-terminal structural domain. It effectively blocks the transcriptional activity of both full-length AR (FL-AR) and AR splice variants (AR-Vs). It has demonstrated antitumor effects, particularly against enzalutamide-resistant castration-resistant prostate cancer (CRPC).
- Inhibits cell proliferation.
- Enhances the effect of enzalutamide.
- Synergistically inhibits AR transcriptional activity.
- Increases G1 phase and decreases S phase, reducing protein expression levels.
- Shows anti-tumor activity in vivo.
- Significantly reduces tumor volume.
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?